At 13.1% CAGR, the Europe Medical Scheduling Software Market is projected to be worth US$ 237.38 million by 2028, says The Business Market Insights

According to the Business Market Insights’ research, the Europe medical scheduling software market was valued at US$ 113.33 million in 2022 and is expected to reach US$ 237.38 million by 2028, registering a CAGR of 13.1% from 2022 to 2028. Rising adoption of patient-centric approach by healthcare providers and surge in use of smart devices for monitoring health are the critical factors attributed to the Europe medical scheduling software market expansion.

A rising in the adoption of advanced technologies in healthcare is allowing patients as well as healthcare service providers to manage personal data and interactions. Smartphones are allowing patients and medical staff to manage hospital schedules and transforming people’s perspectives toward health. Different internet-enabled mobile devices contribute to better management and ease of healthcare practices and data collection. These devices are used to offer services to patients in terms of providing appropriate guidance regarding the physician and the related details of appointment scheduling. Due to the availability of a vast variety of applications with easy access, a large number of people prefer using smartphone apps to avoid waiting times and get convenient appointments.

In recent years, there has been a surge in the number of individuals suffering from heart disease and diabetes. This has underlined the importance of keeping up physical health among people in developed as well as developing countries. Consequently, the demand for various health monitoring devices has also increased in recent years for keeping track of health parameters. Further, the use of handheld and wearable devices for monitoring vital signs has been high among the elderly population as well as millennials. Thus, the surge in the use of smart devices for monitoring health is fueling the medical scheduling software market.

On the contrary, security and privacy issues hurdles the growth of Europe medical scheduling software market.  

Based on software, the Europe medical scheduling software market is segmented into web-based software and installed software. The web-based software segment held 69.4% share of Europe medical scheduling software market in 2022, amassing US$ 78.62 million. It is projected to garner US$ 165.98 million by 2028 to expand at 13.3% CAGR during 2022–2028.

Based on end users, the Europe medical scheduling software market is segmented into hospitals, clinics, and other end users. The hospitals segment held 42.6% share of Europe medical scheduling software market in 2022, amassing US$ 48.29 million. It is projected to garner US$ 101.96 million by 2028 to expand at 13.3% CAGR during 2022–2028.  

Based on country, the Europe medical scheduling software market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe.  Our regional analysis states that Germany captured 27.7% share of Europe medical scheduling software market in 2022. It was assessed at US$ 31.35 million in 2022 and is likely to hit US$ 66.47 million by 2028, exhibiting a CAGR of 13.3% during 2022–2028. 

Key players operating in the Europe medical scheduling software market are Biosoftworld Ltd, SuperSaaS BV, TerminApp GmbH, and WellSky, among others.   

• In May 2022, WellSky CareInsights has won the Healthcare Analytics Innovation Award in the sixth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough.  
• In April 2021, WellSky announced new enhancements to its data analytics solution. The new addition to the CareInsights solution suite, known as CareInsights Guidance, provides actionable visit utilization insights to balance the goals of care quality and patient health improvement with the need to control costs and early adopters of the new capabilities already realize the benefits of their patients, staff, and business.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com